会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 2. 发明公开
    • Matrix metalloprotease inhibitors
    • 基质金属蛋白酶抑制剂
    • EP0780386A1
    • 1997-06-25
    • EP96119780.3
    • 1996-12-10
    • F. HOFFMANN-LA ROCHE AGAGOURON PHARMACEUTICALS, INC.
    • Bender, Steven LeeBroka, Chris AllenCampbell, Jeffrey AllenCastelhano, Arlindo LucasFisher, Lawrence EmersonHendricks, Robert ThanSarma, Keshab
    • C07D309/08C07D211/54C07D213/64C07D401/06C07D407/12C07D413/12C07D405/12A61K31/35A61K31/445
    • C07D213/643C07D211/54C07D309/08C07D401/06C07D407/12C07D409/12C07D413/12Y10S514/825Y10S514/885Y10S514/90Y10S514/903
    • Compounds of the formula:
      wherein:

      n is 0, 1 or 2;
      Y is hydroxy or XONH-, where X is hydrogen or lower alkyl;
      R 1 is hydrogen or lower alkyl;
      R 2 is hydrogen, lower alkyl, heteroalkyl, aryl, aralkyl, arylheteroalkyl, cycloalkyl, cycloalkylalkyl, heteroaryl, heteroaralkyl, heteroarylheteroalkyl, heterocyclo, heterocylo-lower alkyl, heterocyclo-lower heteroalkyl or -NR 6 R 7 , wherein:

      R 6 is hydrogen, lower alkyl, cycloalkyl or cycloalkylalkyl, aryl, heteroaryl and heteroaralkyl;
      R 7 is hydrogen, lower alkyl, cycloalkyl or cycloalkylalkyl, aryl, aralkyl, heteroaryl, heteroaralkyl, -C(O)R 8 , -C(O)NR 8 R 9 , -SO 2 NR 8 R 9 , -SO 2 R 10 , aryloxycarbonyl, or alkoxycarbonyl; or
      R 6 and R 7 together with the nitrogen atom to which they are attached represent a heterocyclo group; wherein

      R 8 and R 9 are independently hydrogen, lower alkyl, cycloalkyl, cycloalkylalkyl, aryl, aralkyl, heteroaryl, heteroaralkyl or heteroalkyl; and
      R 10 is lower alkyl, cycloalkyl, cycloalkylalkyl, aryl, aralkyl, heteroaryl, heteroaralkyl, heteroalkyl or heterocyclo; or


      R 1 and R 2 together with the carbon atom to which they are attached represent a cycloalkyl or heterocyclo group;
      R 3 is hydrogen, lower alkyl, cycloalkyl, cycloalkylalkyl, aryl, aralkyl, heteroaryl, heteroaralkyl, heteroalkyl or lower alkoxy;
      R 4 is hydrogen, lower alkyl, cycloalkyl or cycloalkylalkyl; or
      R 2 and R 3 together with the carbons to which they are attached represent a cycloalkyl or heterocyclo group; or
      R 3 and R 4 together with the carbon to which they are attached represent a cycloalkyl or heterocyclo group; and
      R 5 is lower alkyl, cycloalkyl, cycloalkylalkyl, aryl, aralkyl, heteroaryl, or heteroaralkyl;
      or pharmaceutically acceptable salts or esters thereof exhibit useful pharmacological properties, in particular for use as matrix metalloprotease inhibitors, particularly for interstitial collagenases.
    • 下式的化合物:其中:n为0,1或2; Y是羟基或XONH-,其中X是氢或低级烷基; R 1是氢或低级烷基; R 2是氢,低级烷基,杂烷基,芳基,芳烷基,芳基杂环烷基,环烷基,环烷基烷基,杂芳基,杂芳烷基,杂芳基杂烷基,杂环,杂环 - 低级烷基,杂环低级杂烷基或-NR 6 R 7, 其中:R 6是氢,低级烷基,环烷基或环烷基烷基,芳基,杂芳基和杂芳烷基; R 7是氢,低级烷基,环烷基或环烷基烷基,芳基,芳烷基,杂芳基,杂芳烷基,-C(O)R 8,-C(O)NR 8 R 9,-SO 2 NR 8 R 9,-SO 2 R 10,芳氧基羰基或烷氧基羰基; 或R 6和R 7与它们所连接的氮原子一起代表杂环基; 其中R 8和R 9独立地是氢,低级烷基,环烷基,环烷基烷基,芳基,芳烷基,杂芳基,杂芳烷基或杂烷基。 R 10为低级烷基,环烷基,环烷基烷基,芳基,芳烷基,杂芳基,杂芳烷基,杂烷基或杂环; 或R 1和R 2与它们所连接的碳原子一起代表环烷基或杂环基; R 3是氢,低级烷基,环烷基,环烷基烷基,芳基,芳烷基,杂芳基,杂芳烷基,杂烷基或低级烷氧基; R 4是氢,低级烷基,环烷基或环烷基烷基; 或R 2和R 3与它们所连接的碳一起代表环烷基或杂环基; 或R 3和R 4与它们所连接的碳一起代表环烷基或杂环基; R 5是低级烷基,环烷基,环烷基烷基,芳基,芳烷基,杂芳基或杂芳烷基; 或其药学上可接受的盐或酯表现出有用的药理学性质,特别是用作基质金属蛋白酶抑制剂,特别是用于间质胶原酶。